Silk Road Medical, Inc. - Common Stock (SILK)
Frequently Asked Questions About Silk Road Medical, Inc. - Common Stock (SILK)
How can investors learn more about Silk Road Medical?
Investors can learn more about Silk Road Medical by visiting the company's official website, where they can find information on its products, financial performance, and recent news. Additionally, the company regularly publishes investor presentations, filings, and press releases that provide insights into its growth strategies and market position.
How does Silk Road Medical approach research and development?
Silk Road Medical prioritizes research and development as a cornerstone of its business strategy, continuously investing in innovation to enhance its products. The company collaborates with clinical experts and conducts rigorous studies to evaluate new technologies, ensuring that their offerings meet the evolving needs of medical professionals and patients.
How does Silk Road Medical ensure product quality?
Silk Road Medical adheres to strict regulatory standards and quality control measures to ensure the safety and efficacy of its products. The company follows Good Manufacturing Practices (GMP) and is compliant with regulations set forth by the FDA and other international regulatory bodies, maintaining high standards in every aspect of product development and manufacturing.
Is Silk Road Medical publicly traded?
Yes, Silk Road Medical, Inc. is publicly traded on the NASDAQ stock exchange under the ticker symbol 'SILK.' The company went public in 2019, allowing it to raise capital to support its growth and expand its innovative medical device offerings.
What are the company's values?
Silk Road Medical values innovation, integrity, and collaboration. The company is dedicated to creating groundbreaking medical solutions while prioritizing patient safety and efficacy. It also emphasizes teamwork among its employees and partners to achieve common goals.
What are the competitive advantages of Silk Road Medical?
Silk Road Medical's competitive advantages include its focus on innovation, proprietary technology, and dedicated expertise in carotid artery interventions. The unique ENROUTE Transcarotid Stent System offers procedural benefits that set it apart from traditional methods, potentially leading to better patient outcomes and lower complication rates.
What are the growth prospects for Silk Road Medical?
The growth prospects for Silk Road Medical appear strong, driven by increasing awareness of the risks associated with carotid artery disease and the advantages of minimally invasive procedures. As the company expands its product offerings and penetrates new markets, its innovative solutions may capture a larger share of the interventional market.
What does Silk Road Medical, Inc. do?
Silk Road Medical, Inc. is a medical device company focused on transforming the treatment of vascular diseases, particularly through carotid artery interventions. The company develops innovative products designed to enhance patient outcomes while reducing procedural risks. Their flagship device, the ENROUTE Transcarotid Stent System, is used in minimally invasive surgical procedures aimed at preventing strokes related to carotid artery disease.
What initiatives does Silk Road Medical take in sustainability?
Silk Road Medical is committed to sustainability and applies responsible practices within its operations. The company emphasizes environmental stewardship, manufacturing efficiency, and ethical sourcing of materials, while also focusing on reducing waste and energy consumption throughout its production processes.
What is the company's mission?
Silk Road Medical's mission is to improve patient outcomes by providing innovative medical devices that transform the treatment of carotid artery disease. The company strives to develop solutions that enhance the safety and effectiveness of procedures and maintain a laser focus on patient care.
What is the ENROUTE Transcarotid Stent System?
The ENROUTE Transcarotid Stent System is a medical device designed for the treatment of carotid artery disease. The system provides a minimally invasive approach for stenting and includes a unique delivery system that enables direct carotid access, which can lead to better patient outcomes and reduced procedural risks compared to traditional carotid endarterectomy.
What is the regulatory status of Silk Road Medical's products?
Silk Road Medical’s ENROUTE Transcarotid Stent System has received FDA approval and is CE marked. This regulatory status allows the company to market its product in the United States and Europe, ensuring compliance with safety and efficacy standards.
What markets does Silk Road Medical serve?
Silk Road Medical primarily serves the healthcare market related to vascular surgery and interventional procedures, focusing largely on the treatment of carotid artery disease. Its innovative products aim to benefit hospitals, surgeons, and patients in the U.S. and potentially globally.
What products does Silk Road Medical offer?
The primary product offered by Silk Road Medical is the ENROUTE Transcarotid Stent System, which includes a stent and a delivery system used in carotid artery procedures. The device is designed to allow for direct access to the carotid artery, facilitating safer deployment and reducing the risk of stroke during treatment.
What role does technology play in Silk Road Medical's operations?
Technology plays a pivotal role in Silk Road Medical’s operations, particularly in the design and development of its innovative medical devices. The company utilizes state-of-the-art engineering and design methodologies to create effective and safe products for carotid artery intervention, which improve procedural efficiency and patient outcomes.
What type of partnerships does Silk Road Medical engage in?
Silk Road Medical engages in various partnerships with healthcare providers, clinical researchers, and academic institutions to foster innovation and improve patient care. These collaborations can enhance clinical research efforts, provide valuable feedback on product performance, and expand market reach for its medical devices.
When was Silk Road Medical founded?
Silk Road Medical was founded in 2008. Since its inception, the company has dedicated itself to developing advanced solutions for treating vascular diseases and improving patient outcomes in carotid artery procedures.
Where is Silk Road Medical headquartered?
Silk Road Medical is headquartered in Sunnyvale, California. This central location allows the company to influence the medical device market in Silicon Valley, benefiting from its proximity to technology and innovation.
Who are the key executives at Silk Road Medical?
Some key executives at Silk Road Medical include Chief Executive Officer Erica Rogers, who has extensive experience in the medical device industry, and Chief Financial Officer John B. Deimel. These leaders play crucial roles in guiding the company’s strategic direction and operational execution.
What is the current price of Silk Road Medical, Inc. - Common Stock?
The current price of Silk Road Medical, Inc. - Common Stock is 27.49
When was Silk Road Medical, Inc. - Common Stock last traded?
The last trade of Silk Road Medical, Inc. - Common Stock was at 4:00 pm EDT on September 16th, 2024
What is the market capitalization of Silk Road Medical, Inc. - Common Stock?
The market capitalization of Silk Road Medical, Inc. - Common Stock is 1.12B
How many shares of Silk Road Medical, Inc. - Common Stock are outstanding?
Silk Road Medical, Inc. - Common Stock has 40.63M shares outstanding.